Host: |
HEK293 cells |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Formulation: |
Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Determination Method: |
< 0.1 EU/Mu g of the protein by LAL method. |
Gene Symbol: |
DKK3 |
Gene ID: |
27122 |
Uniprot ID: |
DKK3_HUMAN |
Immunogen Region: |
Ala22-Ile350 |
Immunogen: |
Recombinant Human Dkk-3 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ala22-Ile350) of human Dkk-3/DKK3 (Accession #NP_037385.2 ) fused with a 6×His tag at the C-terminus. |
Immunogen Sequence: |
APAPTATSAPVKPGPALSYP QEEATLNEMFREVEELMEDT QHKLRSAVEEMEAEEAAAKA SSEVNLANLPPSYHNETNTD TKVGNNTIHVHREIHKITNN QTGQMVFSETVITSVGDEEG RRSHECIIDEDCGPSMYCQF ASFQYTCQPCRGQRMLCTRD SECCGDQLCVWGHCTKMATR GSNGTICDNQRDCQPGLCCA FQRGLLFPVCTPLPVEGELC HDPASRLLDLITWELEPDG |
Tissue Specificity | Highest expression in heart, brain, and spinal cord. |
Post Translational Modifications | N- and O-glycosylated. |
Function | Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease. |
Protein Name | Dickkopf-Related Protein 3Dickkopf-3Dkk-3Hdkk-3 |
Cellular Localisation | Secreted |
Alternative Protein Names | Dickkopf-Related Protein 3 proteinDickkopf-3 proteinDkk-3 proteinHdkk-3 proteinDKK3 proteinREIC proteinUNQ258 proteinPRO295 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance